Jul. 13, 2010 (Canada NewsWire Group) --
<< TSX-V: CST NASDAQ: CDXS >>
REDWOOD CITY, CA and
The presentation is being made at the 4th Annual Carbon Capture and Sequestration Business Summit in
Codexis and CO2 Solution are jointly developing this technology, and the companies will describe their development program today. Current carbon capture technology is inefficient and too expensive for large scale deployment. The collaboration focuses on development of customized carbonic anhydrase (CA) biocatalysts and their process applications that have the potential to enable cost-effective, industrial scale capture of CO2 from power plant flue gases. Program results to date have demonstrated the combined proprietary technologies can be used to create CA biocatalysts with improved absorption and stability in industrial conditions.
About the Codexis - CO2 Solution Collaboration
A technology development collaboration between Codexis and CO2 Solution was announced in
About CO2 Solution
CO2 Solution is an innovator in the field of enzyme enabled carbon capture and has been actively working to develop and commercialize the technology for power plants and other large stationary sources of carbon pollution. In the process, CO2 Solution has built an extensive patent portfolio covering the use of carbonic anhydrase, or analogues thereof, for post-combustion capture, including the kinetic enhancement of low-energy amine solutions for efficient CO2 absorption and regeneration. Further information about CO2 Solution can be found at www.co2solution.com.
Codexis, Inc. is a leading provider of optimized biocatalysts that make existing industrial processes faster, cleaner and more efficient than current methods and have the potential to make new industrial processes possible at commercial scale. Codexis has commercialized its biocatalysts in the pharmaceutical industry and is developing biocatalysts for use in producing advanced biofuels under a multi-year research and development collaboration. The company is also using its technology platform to pursue biocatalyst-enabled solutions in other bioindustrial markets, including carbon management, water treatment and chemicals.
Codexis Forward-Looking Statements
This press release contains forward-looking statements relating to Codexis' carbon capture program. You should not place undue reliance on these forward-looking statements because they involve known and unknown risks, uncertainties and other factors that are, in some cases, beyond our control and that could materially affect actual results. Factors that could materially affect actual results can be found in Codexis' Quarterly Report on Form 10-Q dated
CO2 Solution Forward-Looking Statements
Certain statements in this news release may be forward-looking. These statements relate to future events or CO2 Solution's future economic performance and reflect the current assumptions and expectations of management. Certain unknown factors may affect the events, economic performance and results of operation described herein. CO2 Solution undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as may be required under applicable law.
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.